drugset / Trial / NCT02286518
TAK-114 Single- and Multiple-Dose Phase 1 Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of TAK-114 following single and multiple ascending oral doses in healthy Japanese male participants.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Natura-alpha | Unknown | 10 mg | — |
| Subject | Natura-alpha | Unknown | 20 mg | — |
| Subject | Natura-alpha | Unknown | 50 mg | — |
Indications
No indication recorded.